Author of the publication

copy delete add this publication to your clipboard
community post
history of this post
URL
DOI
BibTeX
EndNote
APA
Chicago
DIN 1505
Harvard
MSOffice XML

High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastoma.

J. Schulte, H. Bachmann, B. Brockmeyer, K. Depreter, A. Oberthür, S. Ackermann, Y. Kahlert, K. Pajtler, J. Theissen, F. Westermann, J. Vandesompele, F. Speleman, F. Berthold, A. Eggert, B. Brors, B. Hero, A. Schramm, and M. Fischer. Clin Cancer Res, 17 (15): 5082--5092 (August 2011)
DOI: 10.1158/1078-0432.CCR-10-2809

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Jo Baier

Changyeon Jo

Il Jo

Jó Ueyama

Sungho Jo

Other publications of authors with the same name

CiLiQuant: Quantification of RNA Junction Reads Based on Their Circular or Linear Transcript Origin.A. Morlion, E. Hulstaert, M. Vromman, J. Anckaert, C. Everaert, J. Vandesompele, and P. Mestdagh. Frontiers Bioinform., (2022)Zipper plot: visualizing transcriptional activity of genomic regions.F. Cobos, J. Anckaert, P. Volders, C. Everaert, D. Rombaut, J. Vandesompele, K. Preter, and P. Mestdagh. BMC Bioinform., 18 (1): 231:1-231:9 (2017)RTPrimerDB: the Real-Time PCR primer and probe database.F. Pattyn, F. Speleman, A. Paepe, and J. Vandesompele. Nucleic Acids Res., 31 (1): 122-123 (2003)Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers.A. Oberthuer, D. Juraeva, B. Hero, R. Volland, C. Sterz, R. Schmidt, A. Faldum, Y. Kahlert, A. Engesser, S. Asgharzadeh and 27 other author(s). Clin Cancer Res, 21 (8): 1904-1915 (April 2015)decodeRNA - predicting non-coding RNA functions using guilt-by-association.S. Lefever, J. Anckaert, P. Volders, M. Luypaert, J. Vandesompele, and P. Mestdagh. Database J. Biol. Databases Curation, (2017)Translating expression profiling into a clinically feasible test to predict neuroblastoma outcome.A. Schramm, J. Vandesompele, J. Schulte, S. Dreesmann, L. Kaderali, B. Brors, R. Eils, F. Speleman, and A. Eggert. Clin Cancer Res, 13 (5): 1459--1465 (March 2007)Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature.K. De Preter, J. Vermeulen, B. Brors, O. Delattre, A. Eggert, M. Fischer, I. Janoueix-Lerosey, C. Lavarino, J. Maris, J. Mora and 10 other author(s). Clin Cancer Res, 16 (5): 1532--1541 (March 2010)Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markersA. Oberthuer, D. Juraeva, B. Hero, R. Volland, S. Carolina, R. Schmidt, A. Faldum, Y. Kahlert, A. Engesser, S. Asgharzadeh and 27 other author(s). Clinical Cancer Research, (September 2014)Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.F. Westermann, D. Muth, A. Benner, T. Bauer, K. Henrich, A. Oberthuer, B. Brors, T. Beissbarth, J. Vandesompele, F. Pattyn and 4 other author(s). Genome Biol, 9 (10): R150 (2008)High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastoma.J. Schulte, H. Bachmann, B. Brockmeyer, K. Depreter, A. Oberthür, S. Ackermann, Y. Kahlert, K. Pajtler, J. Theissen, F. Westermann and 8 other author(s). Clin Cancer Res, 17 (15): 5082--5092 (August 2011)

BibSonomy

Disambiguation of "Vandesompele, Jo"

copy delete add this publication to your clipboard
community post
history of this post
URL
DOI
BibTeX
EndNote
APA
Chicago
DIN 1505
Harvard
MSOffice XML

High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastoma.

Please choose a person to relate this publication to

Jo Baier

Changyeon Jo

Il Jo

Jó Ueyama

Sungho Jo

Other publications of authors with the same name

Disambiguation

BibSonomy

Disambiguation of "Vandesompele, Jo"

copydeleteadd this publication to your clipboardcommunity posthistory of this postURLDOIBibTeXEndNoteAPAChicagoDIN 1505HarvardMSOffice XML High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastoma.

Please choose a person to relate this publication to

Jo Baier

Changyeon Jo

Il Jo

Jó Ueyama

Sungho Jo

Other publications of authors with the same name

Disambiguation

copy delete add this publication to your clipboard
community post
history of this post
URL
DOI
BibTeX
EndNote
APA
Chicago
DIN 1505
Harvard
MSOffice XML

High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastoma.